Form SC 13D/A Origin Agritech LTD Filed by: Yuan Liang

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 4)

 

 

Origin Agritech Limited

(Name of Issuer)

Common Stock

(Title of Class of Securities)

G67828106

(CUSIP Number)

Liang Yuan

c/o C201 Shang Ao Century Building

Xisanqi, Haidian District

Beijing 100192, China

(86 10) 8269 4348

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

May 24, 2016

(Date of Event Which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d -1(e), 240.13d -1(f) or 240.13d -1(g), check the following box.  ¨

 

 

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d -7 for other parties to whom copies are to be sent.

 

 

(Continued on following pages)

(Page 1 of 7 pages)

 

 

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

---

13D

 

CUSIP No. G67828106		Page 2 of 7 Pages

 

1		Names of reporting persons   Liang Yuan
2		Check the appropriate box if a member of a group (see instructions) (a)  ¨        (b)  ¨
3		SEC use only
4		Source of funds (see instructions)       OO
5		Check if disclosure of legal proceedings is required pursuant to Item 2(d) or 2(e)    ¨
6		Citizenship or place of organization       The Hong Kong Special Administrative Region of the People’s Republic of China
Number of shares beneficially owned by each reporting person with				7		Sole voting power       -1,586,245-
				8		Shared voting power       -0-
				9		Sole dispositive power       -1,586,245-
				10		Shared dispositive power       -0-
11		Aggregate amount beneficially owned by each reporting person       1,586,245
12		Check box if the aggregate amount in Row (11) excludes certain shares (see instructions)    ¨
13		Percent of class represented by amount in Row 11       6.9%
14		Type of reporting person       IN

 

---

13D

 

CUSIP No. 81943P104		Page 3 of 7 Pages

 

1		Names of reporting persons   Bonasmart Limited
2		Check the appropriate box if a member of a group (see instructions) (a)  ¨        (b)  ¨
3		SEC use only
4		Source of funds (see instructions)       OO
5		Check if disclosure of legal proceedings is required pursuant to Item 2(d) or 2(e)    ¨
6		Citizenship or place of organization       British Virgin Islands
Number of shares beneficially owned by each reporting person with				7		Sole voting power       -1,586,245-
				8		Shared voting power       -0-
				9		Sole dispositive power       -1,586,245-
				10		Shared dispositive power       -0-
11		Aggregate amount beneficially owned by each reporting person       1,586,245
12		Check box if the aggregate amount in Row (11) excludes certain shares (see instructions)    ¨
13		Percent of class represented by amount in Row 11       6.9%
14		Type of reporting person       CO

 

---

This Amendment No. 4 (this “Amendment”) amends and supplements the Schedule 13D filed on November 16, 2005, Amendment No. 1 filed by the Reporting Persons (as defined below) under Schedule 13D/A on November 19, 2014, Amendment No. 2 filed by the Reporting Persons under Schedule 13D/A on December 16, 2014 and Amendment No. 3 filed by the Reporting Persons under Schedule 13D/A on December 30, 2014 (the “Original Schedule 13D” and, as amended and restated by this Amendment, this “Schedule 13D”).

Item 1. Security and Issuer

This Schedule 13D relates to the ordinary shares (the “Ordinary Shares”) of Origin Agritech Limited, a British Virgin Islands company (the “Issuer”). The principal executive offices of the Issuer are located at 21 Shengmingyuan Road, Changping District, Beijing 102206, The People’s Republic of China.

Item 5. Interest in Securities of the Issuer

(a)–(b) As of May 31, 2016, Bonasmart is the record holder of 1,586,245 Ordinary Shares of the Issuer representing approximately 6.9% of the issued and outstanding shares of the Issuer. Mr. Yuan is the beneficial owner of such 1,586,245 Ordinary Shares. The forgoing disclosure assumes that there are a total of 22,843,541 Ordinary Shares outstanding as of March 31, 2016 based on the information provided in the Issuer’s earnings release on Form 6-K filed with the Securities and Exchange Commission on May 5, 2016. Excluded in the foregoing number of shares are 45,000 shares underlying options held by Mr. Yuan.

 

Page 4 of 7

---

(c) Item 5(c) of the Statement is amended and supplemented by inserting the following information:

From April 26, 2016 to May 31, 2016, Bonasmart disposed of 531,200 shares of the Issuser in a series of transactions at prices ranging from $1.6521 to $2.4928 per share in open market transactions on Nasdaq. Details by date, the number of shares disposed of and the price per share are provided below.

 

Date		Price per Share				Shares disposed of
4/26/2016			2.4928				100,000
5/5/2016			1.8077				7,097
5/12/2016			1.8369				13,779
5/16/2016			1.7137				8,320
5/17/2016			1.7092				9,846
5/18/2016			1.7106				38,700
5/19/2016			1.701				2,915
5/20/2016			1.702				7,028
5/23/2016			1.7223				16,100
5/24/2016			1.7965				96,215
5/25/2016			1.7035				95,300
5/26/2016			1.6521				82,700
5/27/2016			1.6826				24,800
5/31/2016			1.72				28,400

Except as set forth in this Item 5, none of the Reporting Persons has effected any transaction in the Ordinary Shares during the past 60 days.

(d) To the best knowledge of the Reporting Persons, no person other than the Reporting Persons has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities beneficially owned by the Reporting Persons identified in this Item 5.

(e) Not applicable.

Item 7. Material to Be Filed as Exhibits

 

1.

Agreement of Joint Filing by Liang Yuan and Bonasmart Limited.

 

Page 5 of 7

---

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: June 2, 2016

 

Liang Yuan				/s/ Liang Yuan
				Liang Yuan
Bonasmart Limited				/s/ Liang Yuan
				Name:		Liang Yuan
				Title:		Director

 

Page 6 of 7

---

INDEX TO EXHIBITS

 

1.

Agreement of Joint Filing by Liang Yuan and Bonasmart Limited.

 

Page 7 of 7

Exhibit 1

Joint Filing Agreement

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the ordinary shares of Origin Agritech Limited, a British Virgin Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

[Signature page to follow]

---

Signature Page

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of June 2, 2016.

 

Liang Yuan				By:		/s/ Liang Yuan
				Name:		Liang Yuan
Bonasmart Limited				By:		/s/ Liang Yuan
				Name:		Liang Yuan
				Title:		Director

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Marriott Vacations Worldwide (VAC) ticks higher on new activist investor
• HOOKIPA Pharma Inc. (HOOK) Receives FDA Clearance of INDA for HB-700